CGM Use for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how continuous glucose monitors (CGMs) can assist people with type 2 diabetes, particularly those with limited access to healthcare. It seeks to understand the benefits and challenges of using CGMs compared to traditional glucose meters over six months. Participants will use either a Freestyle Libre 2 CGM or a traditional glucometer to monitor blood sugar levels. The trial seeks individuals with type 2 diabetes who have high blood sugar levels (A1c > 9%), are on insulin or multiple diabetes medications, and are not currently using an insulin pump. As an unphased trial, this study provides a unique opportunity to contribute to understanding how CGMs can enhance diabetes management for a broader population.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It seems likely that you can continue your current diabetes medications, as the study includes people who are on insulin or two or more diabetes medications.
What prior data suggests that continuous glucose monitoring is safe for underserved adults with type 2 diabetes?
Research has shown that continuous glucose monitors (CGMs), such as the Freestyle Libre 2, are safe for people with diabetes. Studies have found that these devices reduce the time spent with high blood sugar, demonstrating their effectiveness.
No major safety concerns have been reported for the Freestyle Libre system. However, users should take certain precautions. For instance, the sensor should not be used near MRI machines. Additionally, following instructions for sensor removal is important to prevent skin irritation.
Overall, CGMs are easy to use and have been linked to benefits like fewer hospital visits for heart-related issues in people with diabetes. This suggests they are not only effective but also safe for regular use.12345Why are researchers excited about this trial?
Researchers are excited about continuous glucose monitoring (CGM) for Type 2 diabetes because it offers real-time blood sugar tracking, unlike traditional glucometers that require manual testing. CGMs, like the Freestyle Libre 2, provide continuous data, which can help in making timely adjustments to diet and medication. This proactive monitoring allows for better glucose control and potentially reduces the risk of complications associated with Type 2 diabetes.
What evidence suggests that continuous glucose monitoring is effective for type 2 diabetes?
Research has shown that continuous glucose monitors (CGMs), which participants in this trial may use, can help people with type 2 diabetes better control their blood sugar levels. One study found that people using CGMs spent 38% less time with low blood sugar compared to those using traditional methods. Other research indicates that CGMs allow people to track their blood sugar in real-time, simplifying daily diabetes management. These devices have also been linked to fewer hospital visits for heart-related issues in diabetes patients. Overall, CGMs provide a more effective way to manage diabetes than traditional blood sugar monitoring tools, which participants in the traditional glucometer arm of this trial will use.15678
Who Is on the Research Team?
Drew C Prescott, PharmD
Principal Investigator
University of Nebraska
Are You a Good Fit for This Trial?
This trial is for underserved patients with type 2 diabetes who have an A1c level over 9% and are using insulin or at least two diabetes medications. It's not open to those currently on dialysis, pregnant, using an insulin pump, with language barriers (non-English speakers), implanted medical devices, or cognitive/physical disabilities affecting CGM use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either a Continuous Glucose Monitoring (CGM) arm or a traditional glucometer arm for 6 months to track blood glucose levels.
Follow-up
Participants complete a final survey evaluating perceived/expected benefits or barriers to CGM use and willingness to continue CGM use.
What Are the Treatments Tested in This Trial?
Interventions
- Continuous glucose monitor
- Traditional glucometer
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Nebraska
Lead Sponsor
Great Plains IDeA-CTR
Collaborator